GeneLink, Inc.
OTC: GNLKQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Bernard L. Kasten Jr.
- Employees
- 14
- Headquarters
- Orlando, United States
- IPO year
- 1998
- Market cap
- $10.6K
- Website
- https://www.genelinkbio.com
Loading GNLKQ…
Loading profile data…Frequently asked questions about GNLKQ
What does GeneLink, Inc. (GNLKQ) do?
GeneLink, Inc. specializes in delivering 12-gene DNA profiling services. Beyond genetic analyses, the company also provides clients with bespoke nutritional supplements tailored to individual health needs. Additionally, the firm crafts a comprehensive collection of dermatological products. Established in 1994, GeneLink, Inc. maintains its headqu...
Where does GNLKQ trade?
GeneLink, Inc. (GNLKQ) trades on the Other OTC.
What sector is GNLKQ in?
GeneLink, Inc. (GNLKQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of GeneLink, Inc.?
Bernard L. Kasten Jr. is the chief executive officer of GeneLink, Inc. (GNLKQ).
Where is GeneLink, Inc. headquartered?
GeneLink, Inc. is headquartered in United States.
Does GNLKQ pay a dividend?
GeneLink, Inc. (GNLKQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GNLKQ go public?
GeneLink, Inc. (GNLKQ) completed its initial public offering in 1998.